Awarded
Measles, mumps and rubella (MMR) vaccine 2027-2028 (2029, 2030)
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- MSD Finland Oy
- Contract value
- €5,097,600
- Bids received
- 1
- Published
- 7 Sept 2026
- Awarded
- 26 Aug 2026
- Contract start
- 26 Aug 2026
- Contract end
- 27 Aug 2027estimated
- Region
- Helsinki-Uusimaa
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031) | Ministry of Social Affairs and Health | Sanofi Oy | €11,088,000 | 7 Sept 2026 |